</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
CB Partner Webinar 1 hour Dechra {{webinarsautomatedemailsregistrationconfirmation::client_only_logo}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_self_hosted}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_alt}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_width}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_custom_css}} {{webinarsautomatedemailsregistrationconfirmation::client_color}} {{webinarsautomatedemailsregistrationconfirmation::supported_by}} In this free webinar, Dr. Dawn Boothe will discuss how to interpret culture and susceptibility results in dogs and cats, including minimum inhibitory concentration (MIC) interpretation. The concepts and implementation of culture and susceptibility testing as it relates to urinary tract infections in dogs and cats How culture data can be used as the initial basis for selecting a drug The importance of designing dosing regimens based on pharmacodynamics and pharmacokinetic data The importance of high doses and/or short intervals when designing dosing regimens The risk factors for therapeutic failure that impact the design of dosing regimens {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_6}}
Dear #FIRSTNAME#,
Thank you for registering for "#EVENTTITLE#," sponsored by Dechra. Thank you for registering for "#EVENTTITLE#."
In this free webinar, Dr. Dawn Boothe will discuss how to interpret culture and susceptibility results in dogs and cats, including minimum inhibitory concentration (MIC) interpretation.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Learning Objectives
  • The concepts and implementation of culture and susceptibility testing as it relates to urinary tract infections in dogs and cats
  • How culture data can be used as the initial basis for selecting a drug
  • The importance of designing dosing regimens based on pharmacodynamics and pharmacokinetic data
  • The importance of high doses and/or short intervals when designing dosing regimens
  • The risk factors for therapeutic failure that impact the design of dosing regimens
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Webinar Details
#EVENTDAY#, #EVENTDATE#  |  #EVENTTIME# #EVENTTIMEZONESHORT#  |  1 hour
Sponsored by Dechra
Add to Your Calendar
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
#CALENDARREMINDER#
How to Join the Webinar
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
#AUDIENCEURL#
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
Thank you for registering! We look forward to seeing you.
Sincerely,
The Clinician's Brief Team
The Dechra Team
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
Dear #FIRSTNAME#,
Thank you for registering for "#EVENTTITLE#," sponsored by Dechra. Thank you for registering for "#EVENTTITLE#."
In this free webinar, Dr. Dawn Boothe will discuss how to interpret culture and susceptibility results in dogs and cats, including minimum inhibitory concentration (MIC) interpretation.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Learning Objectives
  • The concepts and implementation of culture and susceptibility testing as it relates to urinary tract infections in dogs and cats
  • How culture data can be used as the initial basis for selecting a drug
  • The importance of designing dosing regimens based on pharmacodynamics and pharmacokinetic data
  • The importance of high doses and/or short intervals when designing dosing regimens
  • The risk factors for therapeutic failure that impact the design of dosing regimens
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Webinar Details
#EVENTDAY#, #EVENTDATE#  |  #EVENTTIME# #EVENTTIMEZONESHORT#  |  1 hour
Sponsored by Dechra
Add to Your Calendar
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
#CALENDARREMINDER#
How to Join the Webinar
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
#AUDIENCEURL#
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
Thank you for registering! We look forward to seeing you.
Sincerely,
The Clinician's Brief Team
The Dechra Team